Trial · NCT03032172
Participant flow56
How many started, completed or left each group, period by period.
21 to 40 of 56
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Treatment Period | COMPLETED | OLE Phase: RO6885247 | 0 | |
| Treatment Period | COMPLETED | OLE Phase: Nusinersen | 0 | |
| Treatment Period | COMPLETED | OLE Phase: Olesoxime | 0 | |
| Treatment Period | COMPLETED | OLE Phase: AVXS-101 | 0 | |
| Treatment Period | NOT COMPLETED | Treatment Phase: RO6885247 | 2 | |
| Treatment Period | NOT COMPLETED | Treatment Phase: Nusinersen | 10 | |
| Treatment Period | NOT COMPLETED | Treatment Phase: Olesoxime | 7 | |
| Treatment Period | NOT COMPLETED | Treatment Phase: AVXS-101 | 1 | |
| Treatment Period | NOT COMPLETED | OLE Phase: RO6885247 | 0 | |
| Treatment Period | NOT COMPLETED | OLE Phase: Nusinersen | 0 | |
| Treatment Period | NOT COMPLETED | OLE Phase: Olesoxime | 0 | |
| Treatment Period | NOT COMPLETED | OLE Phase: AVXS-101 | 0 | |
| Open-label Extension Period | STARTED | Treatment Phase: RO6885247 | 0 | |
| Open-label Extension Period | STARTED | Treatment Phase: Nusinersen | 0 | |
| Open-label Extension Period | STARTED | Treatment Phase: Olesoxime | 0 | |
| Open-label Extension Period | STARTED | Treatment Phase: AVXS-101 | 0 | |
| Open-label Extension Period | STARTED | OLE Phase: RO6885247 | 11 | |
| Open-label Extension Period | STARTED | OLE Phase: Nusinersen | 66 | |
| Open-label Extension Period | STARTED | OLE Phase: Olesoxime | 64 | |
| Open-label Extension Period | STARTED | OLE Phase: AVXS-101 | 13 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03032172/flow?page=2